Member Info for KoR_Wraith

"The Board would therefore expect the initial cash proceeds to the Group of the Potential Disposal, should it be completed, to be sufficient to pay off all existing Group bank borrowings, provide significant operating cash and the Company would retain a 20 per cent. interest in the ongoing operations of the Laser Business."

Wow - unbelievable. Best I can tell, rather than sell the company and distribute the net proceeds to shareholders they've come to arrangement whereby they continue to collect salaries whilst providing zero return to shareholders.

The company is primarily ran for the benefits of management, hence the focus on revenue (company size) over profit. They've already communicated that they plan an energy generation division should they ever accumulate enough cash.

"Need a 3rd group

Peptide

Placebo

Nothing

Maybe it’s so happened that the peptide and placebo group both increased the results Vs a nothing group baseline."

I don't think you understand how clinical trials work...

Russian medical trials are treated with mistrust for good reason. More likely the Russian trial was the one with the unusual results.

I wouldn't be so sure:

"The RBL includes the requirement for borrowing base assets, such as Montara, not to have production interrupted for a continuous period of 60 days or more. The Company will also be working with the RBL banks to assess how the shut in might impact the clauses and covenant under the RBL facility."

Clearly the wording here is pre-empting the possibility that the 60 days may be breached.

Current trajectory is for the company to be taken into private ownership (likely by their main supplier) in a distressed sale; their financials are horrible.

I don't know why anyone has any confidence left in this company. Their business model simply doesn't deliver high enough margins to justify itself; revenue is vanity, profit is sanity.

Sell out before their manufacturing buys the IP for a fraction of the current market cap and the lights are turned off.

That's assuming they can stay in business that long

Contract revenue is not the problem here, it's the fact that the company loses money on most contracts it signs.

See Rogue Trader's Youtube video titled "STOCK ANALYSIS UPDATE - Tekmar Group plc"

Looks like we're full steam ahead on the deal going forward.

My sub 7p buys last month are looking good :-)

Regarding the previous comment that sells outnumber buys 6 to 1; my last 3 purchases all appeared as sell trades on LSE; don't rely on it for accurate information.

I voted in favor of the deal with my 500,000 shares.

LTHs will naturally be more willing to roll the dice if they're sitting on a loss, as a new holder I'm quite partial to the proposed deal.

You can't simply get rid of the current BoD, rest assured that they'll not be going anywhere if the Prax deal were not to go ahead. To believe otherwise is fantasy.

Regarding previous discussion about the SP remaining stable despite sells massively exceeding buys, I bought several times today and each of my trades is shown as a sell.

I sympathise with long term holders who bought in at higher prices and have lost money on the trade, but I think the current SP is reasonable value given the proposed deal. I'm much happier investing on the basis that the deal goes ahead than the alternative reality where management buys another asset to secure their salaries rather than wind-down and return cash to shareholders (and that's assuming nothing goes wrong with the field in the mean time).

"So far all we know for sure that 44.89% will be voting yes. We have no idea how the other 55.11% will be voting. That's a lot of unknowns when 75% is required for this deal to be approved."

It just requires 75% of the votes that are placed which is a rather different proposition.

Yes

Those expecting HUR to walk away from a firm deal in the current financial environment are kidding themselves.

Accept it lads, this deal will get the green light regardless of the disquietness of this board.

I'll continue to top up of the SP drops below 7p again.

I'm not overly worried, I bought a little more today.

By my count you'll have received dividends worth almost 27% of your initial investment, or 4.5% annually, which isn't too awful.

At some point this'll head back towards £15, although it may well dip towards £9 before then if things continue to go wrong in the wider market this year. One for patient investors.

Revenue is vanity, profit is sanity - expect major dilution in the next couple of years

Even if they produce and sell 18,000, profit will be tiny compared to their current market cap. Product is excellent but valuation is far too high.

I last looked at this in May when it was trading at 90-100p and decided against investing. The story hasn't changed since then but the SP certainly has.

Ignore the historic chart and promises of future growth. Look at the revenue trend. Current market cap is £72 million and tell me in what decade this company will be able to provide a decent return to shareholders.